Barclays’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-100
| Closed | -$2K | – | 7476 |
|
|
2018
Q2 | $2K | Buy |
+100
| New | +$1.58K | ﹤0.01% | 6857 |
|
|
2017
Q2 | – | Sell |
-10,400
| Closed | -$158K | – | 7018 |
|
|
2017
Q1 | $158K | Sell |
10,400
-400
| -4% | -$5.89K | ﹤0.01% | 4530 |
|
|
2016
Q4 | $142K | Buy |
+10,800
| New | +$138K | ﹤0.01% | 4494 |
|
|
2016
Q3 | – | Sell |
-9,100
| Closed | -$108K | – | 6857 |
|
|
2016
Q2 | $108K | Buy |
9,100
+300
| +3% | +$4.03K | ﹤0.01% | 4353 |
|
|
2016
Q1 | $132K | Buy |
+8,800
| New | +$133K | ﹤0.01% | 4159 |
|
|
2015
Q4 | – | Sell |
-2,500
| Closed | -$30K | – | 6729 |
|
|
2015
Q3 | $30K | Sell |
2,500
-400
| -14% | -$5.49K | ﹤0.01% | 5287 |
|
|
2015
Q2 | $46K | Buy |
2,900
+1,700
| +142% | +$27.4K | ﹤0.01% | 5204 |
|
|
2015
Q1 | $18K | Sell |
1,200
-200
| -14% | -$3.31K | ﹤0.01% | 5894 |
|
|
2014
Q4 | $21K | Sell |
1,400
-1,200
| -46% | -$17.5K | ﹤0.01% | 6307 |
|
|
2014
Q3 | $34K | Sell |
2,600
-3,700
| -59% | -$56.1K | ﹤0.01% | 6161 |
|
|
2014
Q2 | $101K | Sell |
6,300
-6,400
| -50% | -$101K | ﹤0.01% | 5407 |
|
|
2014
Q1 | $203K | Buy |
12,700
+10,500
| +477% | +$190K | ﹤0.01% | 4785 |
|
|
2013
Q4 | $46K | Sell |
2,200
-10,600
| -83% | -$239K | ﹤0.01% | 6237 |
|
|
2013
Q3 | $269K | Sell |
12,800
-15,400
| -55% | -$329K | ﹤0.01% | 4759 |
|
|
2013
Q2 | $528K | Buy |
+28,200
| New | +$514K | ﹤0.01% | 4142 |
|
Other funds holding NXGN
Barclays's NXGN Position: Q4 2023 in Review
Barclays sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 87,444 shares — an estimated $2.08M sold.
Barclays first reported a position in NXGN in Q2 2013 and held it in 42 quarters. The position peaked at $5.28M in Q3 2013. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Barclays reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Barclays sold 87,444 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $2.08M.
- Barclays first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
- Barclays's NextGen Healthcare, Inc. Common Stock position peaked at $5.28M in Q3 2013.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.